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 ORIGINAL ARTICLE
Profibrotic Activity of Multiwalled Carbon Nanotubes
Upon Prolonged Exposures in Different Human
Lung Cell Types
Savvina Chortarea,1,2 Fikad Zerimariam,1 Hana Barosova,1 Dedy Septiadi,1
Martin J.D. Clift,1,3 Alke Petri-Fink,1,4 and Barbara Rothen-Rutishauser1
Abstract
Introduction: The expanding use of multiwalled carbon nanotubes (MWCNTs) in various consumer and indus-
trial products has raised concerns regarding the potential health risks following the inhalation of this nanomate-
rial. Recent studies indicate that MWCNT exposure can cause deleterious lung effects. Pulmonary fibrosis is one
of the diseases associated with the inhalation of classical fiber-shaped materials (e.g., asbestos), and recently
MWCNTs.
Materials and Methods: Herein, the presented work investigated early signs of fibrosis in key human lung cell
types implicated directly (fibroblasts) or indirectly (alveolar epithelial cells and macrophages) in the pathogen-
esis of lung fibrosis, upon acute (24 hours) and prolonged (96 hours) exposure to different concentrations
(5–20lg/mL) of long, rigid Mitsui-7 MWCNTs. These results were compared to those inflicted upon the
same cell types following exposure to tangled nanofibers, that is, Nanocyl-7000, and a positive particle control,
crystalline quartz (i.e., Min-U-Sil).
Results:Mitsui-7 interacted with all cell types tested, in particular, single nanotubes were readily internalized by
each cell type. Exposure to Mitsui-7 resulted in a proinflammatory response in macrophages at 24 hours
(interleukin-1b release). However, only prolonged Mitsui-7 exposure induced a significant release of profibrotic
mediators (transforming growth factor-b, platelet derived-growth factor, and osteopontin) in all tested cell cul-
tures and concentrations, highlighting the importance of prolonged exposure studies in nanosafety assessment.
This elevated release of profibrotic markers was not accompanied by an increased collagen production or cell
proliferation in fibroblasts in the tested time frame.
Conclusion: Overall, prolonged exposure to human-relevant CNT concentrations appears to be a highly suitable
approach to predict profibrotic response in vitro.
Keywords: acute and prolonged exposures, hazard assessment, in vitro lung cell cultures, multiwalled carbon
nanotubes, profibrotic response
Introduction
During the past two decades, the incorporation ofengineered nanomaterials (NMs) in consumer and in-
dustrial applications has tremendously increased.1 In fact,
since 2006, the use of NMs in everyday products has more
than quadrupled, subsequently raising public concerns re-
garding their potential human health effects during the prod-
ucts life cycle.2
Among the variety of existing engineered NMs, the ex-
traordinary properties of carbon nanotubes (CNTs), including
remarkable tensile strength, thermal stability, and excellent
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electrical conductivity, have heightened worldwide commer-
cial interest.3–5 However, the expanding use of CNTs has
raised concerns, due to their potential biopersistence and
high aspect ratio that are similar to specific types of micron-
sized asbestos fibers. Such concerns were raised from several
studies that indicated that exposure to CNTs may be associ-
ated with carcinogenic activity in the lung.6–9 The potential
risk is increased for long, thin fibers with high rigidity as
they are able to reach deeper lung regions, where they can re-
main for extended periods due to impaired macrophage
clearance.10–12 Indeed, recent in vivo studies reported in-
creased lung injury, inflammation, fibrosis, and granuloma
formation, following exposure to long multiwalled CNTs
(MWCNTs) (10–30 lm).13,14 Taken into consideration that
human exposure to CNTs is highly possible within occupa-
tional, consumer, or environmental setting, there is height-
ened concern as to the pathogenic potential of CNTs.4
One of the most serious consequences of the inhalation of
fiber-shaped NMs, and other micron-sized, particulate materi-
als, for example, crystalline silica, is lung fibrosis.15 Various
in vivo and in vitro studies have investigated the profibrotic
potential of MWCNTs; however, contradictory results have
been reported.16–21 The different findings have been attributed
to differences in the mode of exposure, cell models used, prep-
aration of test samples, and dose metrics. Despite the incon-
sistent conclusions, it has been indicated that MWCNTs
physicochemical characteristics, that is, aspect ratio, size, im-
purities, rigidity, or surface functionalization, as well as dis-
persion state and doses applied can influence their potential
fibrogenic capacity.22–24 Therefore, it is of great importance
to clearly identify which properties of CNTs can be correlated
with such an adverse biological impact.
In the development of lung fibrosis, a key biological event is
the activation of fibroblasts, which are the most common cells
in the connective tissue.15,25 In particular, chronic inflammation
or extended tissue injury can result in lung fibrosis as a result of
uncontrolled fibroblast proliferation, transformation into myofi-
broblasts, and increased production of extracellular matrix
(ECM) constituents.22,26 The effects of CNTs on fibroblasts
can be described as related to either a direct or indirect interac-
tion.15 Recent in vivo studies provided evidence that well-
dispersed CNTs can reach the alveolar interstitium, where
they can come in contact and directly act on fibroblasts, thus
conceivably contribute to fibrosis.13,18 On the other hand,
CNTs can trigger cells in the frontline of the alveolar tissue bar-
rier, that is, macrophages and epithelial cells, to release proin-
flammatory and profibrotic mediators, which then in turn
indirectly mediate fibroblasts recruitment and activation.27,28
The aim of our study was to investigate both the ‘‘direct’’
and ‘‘indirect’’ proinflammatory and profibrotic activity of
Mitsui-7 MWCNTs using monocultures (cell lines) of
human lung alveolar epithelial cells, macrophages, and fibro-
blasts, by assessing the biological impact of different
MWCNT concentrations on each cell culture type indepen-
dently. The adverse effects associated with MWCNT expo-
sure have so far mainly been investigated in vitro upon
acute exposures (up to 24 hours) to high CNT doses (up to
150 lg/mL), but the proinflammatory and profibrotic activity
of lower, more realistic, and human-relevant concentrations
combined with prolonged time periods are not yet described.
Therefore, the cellular response at low concentrations (rang-
ing from 5–20lg/mL) was evaluated by applying an acute
(24 hours) and prolonged (96 hours) exposure duration. It is hy-
pothesized that the MWCNTs will interact with all cell types,
while they might cause different key proinflammatory and pro-
fibrotic effects depending on the cell type and the time frame of
exposure.
Materials and Methods
Chemical and reagents
All chemicals and reagents used were obtained from
Sigma-Aldrich (Switzerland), unless otherwise stated.
Cell cultures
Human alveolar type II epithelial cells. Alveolar epithelial
type II A549 cells (ATCC CCL-185) were cultured in
Rosewell Park Memorial Institute (RPMI) 1640 medium
supplemented with 10% fetal calf serum (FCS; Gibco, Zug,
Switzerland), 1% l-Glutamine (L-Glut; Life Technologies,
Europe, Zug, Switzerland), and 1% penicillin/streptomycin
(P/S) (10,000 units/mL/10,000 lg/mL; Gibco, Zug, Switzer-
land) and maintained at 37C and 5% CO2. Cells were seeded
at a density of 5·105 cells/insert in 12-well BD Falcon cell
culture inserts (0.9 cm2 growth area, 1.0lm pore size, and high
density polyethylene terephthalate [PET] membrane) under
submerged conditions (i.e., 1mLmedium in the apical chamber
and 1.5mL of medium in the basal chamber) for 3 days.
Human macrophages. Similar to A549 cells, the THP-1
peripheral blood monocyte cell line (ATCC TIB-202)) was
cultured in supplemented RPMI medium with the addition of
0.05mM b-mercaptoethanol to avoid cell agglomeration. To
differentiate THP-1 monocytes into macrophages, 0.02lM
of Phorbol-12-myristate 13-acetate (PMA; Sigma-Aldrich,
Switzerland) was added to the cell cultures. Following
24 hours of incubation, 6· 104 cells/insert were seeded on
12-well inserts (0.9 cm2 growth area, 1.0lmpore size, high den-
sity PET membrane) for 3 days under submerged conditions.
Human lung fibroblasts. The MRC-5 lung fibroblast
cell line (ATCC CCL-171) was maintained in Minimum
Essential Medium (MEM) supplemented with 10% FCS,
1% l-Glut, 1% P/S, and 1% of MEM nonessential amino
acid (Sigma Aldrich, Switzerland) solution at 37C and
5% CO2. Fibroblasts were seeded in 12-well BD Falcon
cell culture inserts at a density of 9·103 cells/insert and cultured
for 4 days under submerged conditions.
Preparation of MWCNT suspension and control samples
MWCNTs (Mitsui-7; Mitsui & Co, Japan) were kindly pro-
vided by Prof. Vicki Stone, Heriot-Watt University, Edinburgh,
United Kingdom, and used without any further purification.
They were dispersed in bovine serum albumin (BSA;
1mg/mL in H2O) to obtain a well-dispersed suspension for
exposure experiments. Briefly, to prepare the stock suspen-
sion, dry MWCNT powder was weighed and heat sterilized
overnight at 100C. Then, 1mg/mL BSA—observed optimal
BSA concentration for the dispersion of MWCNTs (data not
shown)—was added in the vial and sonicated for an addi-
tional 3 hours. The MWCNT suspension was stored at 4C,
until required for experimentation. Before exposure, the
stock suspension was sonicated for 1 hour to disperse
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agglomerates and was then diluted to the working concentra-
tions (5, 10, and 20lg/mL) in supplemented cell culture
medium.
BSA-treated cells (i.e., cells treated with 1mg/mL BSA)
were used as negative control cultures. To examine the differ-
ence in cellular response between different MWCNT types,
the biological impact upon cells exposed to short, entangled
Nanocyl-7000 MWCNTs (obtained from European Commis-
sion Joint Research Centre, ISPRA, Italy; originated from
Nanocyl S.A., Belgium) at a concentration of 20lg/mL was
also assessed. The dispersion method for Nanocyl-7000 was
the same as forMitsui-7MWCNTs. In addition, a referencema-
terial for profibrotic response, that is, crystalline silica, Min-U-
Sil, was used as positive particle and fibrotic control as various
studies have shown that it can cause fibrosis in vivo.29,30 Min-U-
Sil was dispersed in autoclaved ultrapure water to prepare a
stock suspension of 1mg/mL and sonicated for 1 hour to obtain
a well-dispersed suspension. The stock solution was then further
diluted to the working concentration of 25lg/mL—an optimal
concentration for a continuous 96 hours of exposure, as higher
Min-U-Sil concentrations resulted in significant cell death (data
not shown)—with supplemented cell culture medium.
Transmission electron microscopy
To characterize the MWCNTs’ dispersed suspensions,
4 lL of stock suspension was added on a transmission elec-
tron microscopy (TEM) copper grid and left to air dry before
visualization by TEM. Representative images of MWCNTs
were captured using an FEI Technai Spirit (Oregon), oper-
ating at 120 kV. Images were recorded with a Veleta CCD
camera (Olympus, Japan). The average length and width
distribution of suspended MWCNTs were derived from cap-
tured TEM images, measuring*200 individual CNTs using
ImageJ software.31
Endotoxin content
The endotoxin concentration in CNT suspensions was
measured using the Pierce LAL Chromogenic Endotoxin
Quantitation kit (ThermoFisher Scientific), following the
manufacturer’s instructions.
Exposure scenarios
The biological response of different lung cell cultures, fol-
lowing suspension MWCNT (Mitsui-7) exposure, was evalu-
ated at exposure concentrations ranging from 5 to 20lg/mL.
The cellular impact was assessed at two exposure scenarios:
(i) following acute, continuous MWCNT exposure of 24
hours and (ii) after prolonged 96 hours of continuous expo-
sure. Cells were exposed apically (1mL of material suspen-
sion added to the apical chamber) and kept at 37C in 5%
CO2 throughout each exposure scenario. For the 96-hour ex-
posure strategy, the cell culture medium after 48 hours was as-
pirated and replaced with fresh cell culture medium containing
the test materials, to provide the necessary nutrients for the
cell survival under prolonged experimental settings and main-
tain them at a continuous exposure environment. Of note is
that, for the 96-hour exposures, the cell cultures received
two repeated doses of the materials under investigation (one
dose at the beginning of the experiment [0 hours] and one
after 48 hours as described above).
Interaction of MWCNTs with lung cells
Cytoviva-enhanced dark-field microscopy. To investigate
the interaction of Mitsui-7 MWCNTs within the different
monoculture types, cells were seeded in detachable four-
well culture slides (BD Falcon; 1.7 cm2; working volume
0.7–1.24lL) and exposed to 5 and 10 lg/mL (images were
not captured at the concentration of 20 lg/mL as the large
amount of tubes in the samples was greatly scattering and
subsequently resulted in out of focus images) of Mitsui-7
MWCNTs for 24 or 96 hours. At the respective time points,
the cell cultures were fixed for 15 minutes in 4% paraformal-
dehyde (PFA) in PBS at room temperature and subsequently
stored (after 3 ·washes with PBS) in PBS at 4C until immu-
nofluorescent staining could occur.
Samples were treated with 0.1M glycine for 15 minutes and
subsequently permeabilized with 0.2% Triton X-100 for an-
other 15 minutes, all at room temperature. Samples were subse-
quently stained with rhodamine phalloidin (R-415; Molecular
Probes, Life Technologies Europe B.V., Zug; dilution 1:50)
and 4¢,6-diamidino-2-phenylindole (DAPI) (Sigma Aldrich,
Switzerland; dilution 1:50) for identification of F-actin cytoskel-
eton and nucleus, respectively. Coverslips were then placed on
top of the microscope slides using Glycergel (DAKO Schweiz
AG, Baar, Switzerland). Samples were scanned using a
100·objective lens (numerical aperture 0.6 and 1.2) in Cyto-
viva dual mode fluorescence-enhanced dark-field microscopy
setup (Cytoviva, Inc., Auburn).32
Biochemical analysis
Cytotoxicity. The release of lactate dehydrogenase (LDH)
into the supernatant, a well-known indicator of membrane im-
pairment,33 was evaluated using a commercially available
LDH diagnostic kit (Roche Applied Science, Mannheim,
Germany), according to the manufacturer’s protocol. Each
sample was tested in triplicate and LDH values were expressed
relative to the negative control (BSA-treated cells). Determi-
nation of the enzyme activity was performed photometrically
by measuring the absorbance at 490 nm (reference wavelength
at 630 nm). Cell cultures exposed apically to 0.2% Triton
X-100 for 24 hours were used as a positive control.
Cell morphology
Laser scanning microscopy. After the respective time
points (24 or 96 hours), cell cultures were fixed and permeabi-
lized as described above in the Cytoviva analysis section. All
antibodies were diluted in 0.3% Triton X-100 and 1% BSA
in PBS and incubated for 2 hours. Cells were stained with rho-
damine phalloidin (dilution 1:50, excitation/emission: 540/
565 nm) and DAPI (dilution 1:50, excitation/emission: 405/
461 nm) for F-actin cytoskeleton and nucleus, respectively. Fol-
lowing antibody incubation, membranes were embedded in
Glycergel. Cellular morphology was determined through visu-
alization of samples by using an inverted laser scanning confo-
cal microscope (laser scanning microscopy [LSM] 710 (Axio
Observer.Z1, Carl Zeiss, Germany, magnification 63· , numer-
ical aperture 1.4). Image processing was conducted with Imaris
3D restoration software (Bitplane AG, Zurich, Switzerland).
Oxidative stress
The total amount of reduced glutathione (GSH) in the cell
cultures was quantified by using a GSH assay kit (Cayman
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Chemical Company, Ann Arbor), following the supplier’s in-
structions. GSH values are expressed as a ratio to the total
amount of protein of each sample, as measured by the Pierce
bicinchoninic acid protein assay kit (Pierce Protein research
Products; Thermo Scientific, Rockford), according to the
manufacturer’s guidelines.
Cytokine secretion
Proinflammatory response. Interleukin (IL)-8 and IL-1b
secretion were assessed using the commercially available Duo-
Set Enzyme-linked Immunosorbent Assay (ELISA) Develop-
ment diagnostic kit (R&D Systems, Switzerland), according to
manufacturer’s protocol. Cells treated apically with 1lg/mL
of tumor necrosis factor-a for 24 hours served as the positive
assay control.
Profibrotic response. Transforming growth factor-b1
(TGF-b1), platelet-derived growth factor-AA (PD-GF), and
osteopontin (OPN) released into the supernatant of exposed
cells were quantified using the respective ELISA DuoSet
Development diagnostic kit, following the manufacturer’s
protocol. Cell cultures exposed apically to 1 lg/mL of inter-
feron gamma for 24 hours were used as a positive control
for TGF-b; while apical cell treatment with 100 ng/mL
TGF-b served as the positive control for both PD-GF and
OPN secretion.
Collagen formation
Collagen production by fibroblasts was quantified using the
commercially available Sircol assay (Biocolor Ltd., United
Kingdom), following the supplier’s instructions. The amount
of soluble collagen in the supernatant was examined photo-
metrically by measuring the absorbance at 555nm. Cells trea-
ted apically with TGF-b (100 ng/mL) served as a positive
control.
Fibroblast proliferation
Following 24 or 96 hours of exposure, MRC-5 cells were
labeled with BrdU (5-bromo-2¢-deoxyuridine) labeling solu-
tion and further incubated for 3 hours at 37C. Subsequently,
cells were washed to remove BrdU solution and fixed in 4%
PFA for 15 minutes. Samples were then prepared according
to the manufacturer’s protocol (BrdU labeling and detection
assay, ThermoFisher Scientific). Membranes were also
stained with DAPI for 30 minutes to label cell nuclei. Sam-
ples were visualized by confocal microscopy (Zeiss LSM
710), as previously described. Cell counting using image-
based analysis was performed automatically using a self-
written Matlab script. The percentage of proliferating cells
was obtained by dividing the total number of BrdU-stained
cells over the total population of cells.
Statistical analysis
For each data point, three independent experiments (n = 3)
were performed and all data are presented as the mean – stan-
dard error of the mean. Statistical analysis was performed
using GraphPad Prism 6 (GraphPad Software, Inc., La
Jolla) software. A parametric one-way analysis of variance
with subsequent Dunnett test was performed. Results were
considered significant if p< 0.05.
Results
MWCNT characteristics
MWCNT dispersion (both Mitsui-7 and Nanocyl-7000) in
1mg/mL BSA resulted in a well-dispersed CNT suspension.
Representative TEM images revealed different morphologies
for the two CNT types. Mitsui-7 MWCNTs appear as rela-
tively well-dispersed, small bundles or singlets of long
and intermediate-length nanotubes. Nanocyl-7000 suspen-
sions consists of shorter, thinner and highly entangled tubes
(Fig. 1A, Supplementary Fig. S1A; Supplementary Data are
available online at www.liebertpub.com/aivt). Mitsui-7 sus-
pension revealed an average length of 5.66– 4.7lm and diam-
eter of 60.1– 18.2 nm (Fig. 1B–D). Notably, the length of
Mitsui-7 suspended tubes is considerably shorter, compared
to nonsuspended tubes in powder form, as measured by pre-
vious studies.8,18 It was not possible to determine the size
distribution of Nanocyl-7000 in suspension due to their in-
creased agglomeration under these conditions. However,
Nanocyl-7000 dry powder has been fully characterized previ-
ously (Supplementary Fig. S1), indicating an average length
of 4– 0.4lm and diameter of 11– 4 nm.34,35 Endotoxin con-
tent of both MWCNT suspensions was found to be below
the detection limit. Other key physicochemical characteristics
such as metal contaminants for both MWCNT samples are
summarized in Figure 1D and Supplementary Figure S1B.
MWCNT-lung cell interaction
Using fluorescence-enhanced dark-field microscopy, it was
possible to visualize the interaction of Mitsui-7 MWCNTs at
two concentrations (5 and 10lg/mL), with the three lung
cell cultures (A549, MRC-5, and THP-1 cells) under both ex-
posure scenarios, that is, 24 and 96 hours. It was apparent from
a first observation that a concentration-dependent interaction
(internalization or attachment to the cellular membrane) was
notable with all cell types for each MWCNT type studied.
Notably, some THP-1 macrophages showed an increased asso-
ciation with MWCNTs, compared to epithelial or fibroblast
cell cultures (Fig. 2A–C, Supplementary Fig. S2A–C), possibly
because of their phagocytic activity36 in comparison to the
other cell types investigated. As shown from the 3D-rendered
images, the cellular uptake of single short tubes or small ag-
glomerates occurs in all three cell types, while large agglomer-
ates are mainly attached on the cells surface (Fig. 2A–C).
Cytotoxicity and cell morphology
Exposure to different Mitsui-7 MWCNT concentrations
did not elicit any significant cytotoxic response upon acute
(24 hours) or prolonged exposures (96 hours) in any of the
tested cell culture types (Fig. 3A). Similarly, no significant cy-
totoxicity (p> 0.05) was observed following exposure to
Nanocyl-7000 or Min-U-Sil. Various studies have reported
that MWCNTs might interfere with commonly used in vitro
biological assays (e.g., cytotoxicity and viability tests).37 There-
fore, in this study, NM suspensions were evaluated for potential
interference with the assays used and no interference was
detected at the tested concentrations (Supplementary Fig. S3).
No alterations in cellular morphology were observed by
LSM in A549 epithelial cells treated with 5 and 10 lg/mL
of Mitsui-7 MWCNT for 24 hours, compared to negative
control cultures. However, A549 cells exposed to the highest
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Mitsui-7 concentration (20 lg/mL) revealed slight alter-
ations to cellular morphology after 24 hours, which became
more pronounced after 96 hours of exposure (Fig. 3B and
Supplementary Fig. S4A). In fact, after acute (24 hours) ex-
posure to 20 lg/mL of Mitsui-7, the epithelial cells started to
disorganize, losing cellular contacts. Furthermore, following
long-term (96 hours) treatment, the cells lost their regular cu-
boidal shape, showing either rounded or a spindle-like ap-
pearance. Morphological changes were not observed in
THP-1 macrophages or MRC-5 fibroblasts following
24 hours of Mitsui-7 MWCNT exposure (Fig. 3B), but pro-
longed 96 hours of exposure resulted in an apparent alter-
ation in F-actin cytoskeleton staining in both macrophages
and fibroblasts, when compared to negative control cultures,
FIG. 1. Morphology, size distribution, and physicochemical characteristics of Mitsui-7 MWCNTs. (A) Transmission elec-
tron microscopy image of MWCNT stock suspension. Histogram represents the (B) length (in lm) and (C) width (in nm)
distribution, respectively, of dispersed Mitsui-7 MWCNTs. (D) The table summarizes the key physicochemical characteris-
tics of Mitsui-7 MWCNTs. ND, not detectable; MWCNTs, multiwalled carbon nanotubes.
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thus indicating an impact on these cell types upon extended
exposure time frames (Supplementary Fig. S4B–C).
Oxidative stress response
Total GSH content was assessed as an important marker
for oxidative stress.38 Both epithelial and fibroblast cell
lines showed a slight loss in intracellular GSH levels at
20 lg/mL of Mitsui-7 following 24 hours of exposure
(Fig. 4A and C). At the same time point, macrophages
showed a notable decrease (not statistically significant) in
GSH at both 10 and 20lg/mL of Mitsui-7 (Fig. 4B). Follow-
ing 96 hours of exposure, a decrease (not statistically signif-
icant) of GSH was observed in both A549 epithelial and
THP-1 macrophage cell cultures at all Mitsui-7 concentra-
tions tested. Acute 24 hours of exposure to Nanocyl-7000
MWCNTs resulted in decreased GSH in all cell culture
types (significant for MRC-5 cells, p < 0.05). Similarly, a de-
crease in GSH was observed at the 96-hour time point in
epithelial cells only, while no effect was shown in Nanocyl-
7000 exposed MRC-5 or THP-1 cells. At 24 hours, Min-U-
Sil induced a clear effect in intracellular GSH content in
both fibroblast ( p< 0.05) and macrophage cultures. Prolonged
exposure to Min-U-Sil led to GSH reduction in epithelial and
macrophages cells, although not significant ( p> 0.05) when
compared to the negative controls.
Proinflammatory response
Acute or prolonged exposures to different concentrations of
Mitsui-7 did not induce any significant effect on the level of
secreted IL-8 in any of the tested cell types (Fig. 5A–C). IL-
8 levels were increased in Nanocyl-7000 exposed A549 and
THP-1 cells at 96 hours, although this increase was not statis-
tically significant compared to negative control. IL-8 secretion
appeared to be increased, in A549 cells following either 24 or
96 hours of exposure to Min-U-Sil, but it was not determined
to be statistically significant.
THP-1 cells have been successfully used to investigate the
proinflammatory effect of MWCNTs and other high aspect
ratio materials, for example, asbestos fibers and nanowires,
on the induction of IL-1b secretion.39 The synergy between
IL-1b release and TGF-b production plays a crucial role in
excess collagen production and deposition in the lung.40,41
FIG. 2. MWCNT-lung cell interac-
tion upon acute MWCNT exposure.
Fluorescence-enhanced dark-field
microscopy images of (A)A549, (B)
THP-1, and (C) MRC-5 cells ex-
posed to 5 and 10lg/mL of Mitsui-7
MWCNTs for 24 hours. Magenta
color shows F-actin (cytoskeleton),
blue color represents DNA (cell nu-
clei), and green color shows Mitsui-
7 MWCNTs. White arrows point out
the internalized MWCNTs.
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Notably, a statistically significant IL-1b release ( p< 0.05) was
observed in fibroblasts exposed to the lowest Mitsui-7 dose
(5lg/mL) at the 24-hour time point, however, not for the
higher concentrations in both 24- and 96-hour scenarios, com-
pared to control cultures (Fig. 5C). At the same time point,
THP-1 cells also showed significant IL-1b secretion at 5lg/
mL ( p< 0.05; Mitsui-7), as well as an apparent, but statistically
insignificant, increase at 20lg/mL (Mitsui-7). Prolonged
96 hours of exposure at the lowest dose (5lg/mL) of Mitsui-
7 also elicited notable IL-1b release; however, this increase
was not found to be statistically significant. Prolonged expo-
sure to Min-U-Sil resulted in a statistically significant IL-1b
( p< 0.05; 96 hours) release in THP-1 macrophages.
Profibrotic response
Recent studies have shown that TGF-b released by alveolar
epithelial cells and macrophages contributes to the pathogen-
esis of pulmonary fibrosis (in synergy with IL-1b induction);
therefore, the secretion of TGF-b levels in the supernatant was
assessed in the tested cell types.41 Acute exposures to 5, 10, or
20lg/mL Mitsui-7 MWCNT concentrations for 24 hours did
FIG. 3. Cytotoxicity and cellular morphology of MWCNT-exposed lung cell cultures following 24 and 96 hours of exposure. (A)
Cytotoxicity as estimated by quantification of LDH release in cell culture medium in A549 epithelial, THP-1 macrophage, and
MRC-5 fibroblast cell lines. Data are presented as the mean–SEM relative to negative control. Dashed line represents the
level of negative control. *Represents a significant increase (p< 0.05) compared to the negative control at 24-hour time point.
#Indicates statistical significance in lung cultures at 96 hours, compared to the negative control (p<0.05). (B) LSM images of
cells following acute (24 hours) Mitsui-7 MWCNT exposure. Blue color shows the DNA (cell nuclei) and pink color shows
the F-actin cytoskeleton. LSM, laser scanning microscopy; SEM, standard error of the mean.
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not induce TGF-b release in any of the tested cell types
compared to the negative control. Importantly, however, pro-
longed 96-hour exposure to the same Mitsui-7 concentrations
elicited a statistically significant TGF-b secretion in both
A549 and MRC-5 cells (but not in THP-1 cells) (Fig. 6A
and C). In contrast, Nanocyl-7000 exposure for 24 hours
and Min-U-Sil for both 24 and 96 hours resulted in a signifi-
cant increase in TGF-b protein levels ( p< 0.05) in A549
(Fig. 6A) and MRC-5 cultures (Fig. 6C).
PD-GF levels were not altered after 24 hours of exposure
to Mitsui-7 in any of the tested cell types and only Nanocyl-
7000 andMin-U-Sil induced a significant effect in fibroblasts
after 24 hours. However, prolonged (96 hour) Mitsui-7 expo-
sure induced elevated PD-GF secretion in A549 and MRC-5
cells (statistically significant only for A549 cells at all tested
concentrations; Fig. 6).
Mitsui-7 exposure infibroblasts for 24 hours elicitedOPN re-
lease at the lowest (5lg/mL; p< 0.05) and highest (20lg/mL)
FIG. 4. Cellular response to oxidative stress upon acute or prolonged exposure to different concentrations of Mitsui-7
MWCNTs. GSH levels in (A) A549, (B) THP-1, and (C) MRC-5 monocultures after 24-hour (gray) and 96-hour (black)
exposures to MWCNTs and the controls. Data are presented as the mean – SEM of at least three independent experiments.
Values were considered significantly different compared to the negative control (BSA-treated cells) with p < 0.05 (*24-hour
exposure). BSA, bovine serum albumin; GSH, glutathione.
FIG. 5. Proinflammatory response in human lung cultures exposed to different concentrations of Mitsui-7 MWCNTs for up
to 96 hours. Quantification of total Interleukin 1-beta (IL-1b) and IL-8 secretion in (A) A549 epithelial, (B) THP-1 macro-
phage, and (C)MRC-5 fibroblast cell lines upon 24- or 96-hour exposures. *Represents a significant increase ( p < 0.05) com-
pared to the negative control at 24-hour time point. #Indicates statistical significance in lung cultures at 96 hours, compared to
the negative control ( p < 0.05).
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concentrations tested. Of note, A549 (Fig. 6A) and THP-1
(Fig. 6B) cells showed a statistically significant ( p< 0.05)
OPN release at the 96-hour time point following exposure to
5, 10, or 20lg/mL Mitsui-7. Min-U-Sil induced a statistically
significant ( p< 0.05) OPN response after 96 hours in macro-
phages, but not in the other two cell types tested.
Finally, the differential secretion of markers observed in the
apical and basolateral compartment can be attributed to the rel-
ative small pore size (1lm) of the inserts, which might reduce
the diffusion speed of markers from the apical to the basal side.
Fibroblast activation
Activation of fibroblasts (MRC-5 cell line) after exposure
to MWCNTs was investigated by quantifying the levels of
soluble collagen production and by observing cell prolifera-
tion. No significant changes were observed in collagen pro-
duction in fibroblasts exposed to Mitsui-7 at both 24- and
96-hour time points, compared to the negative control (Sup-
plementary Fig. S5A). A slight increase in collagen levels
was only seen in cells exposed to highest concentration of
Mitsui-7 (20lg/mL) for 24 hours, although not statistically
significant ( p > 0.05). Only exposure to Min-U-Sil induced
a significant increase ( p < 0.05) in collagen production
after 96 hours.
Proliferating fibroblasts were visualized for all tested con-
centrations in both acute and prolonged exposure scenarios
(Supplementary Fig. S5C). Semiquantitative image-based anal-
ysis using BrdU staining of fibroblasts demonstrated a decrease
in the percentage of proliferating cells in Mitsui-7-exposed cells
compared to the negative control cultures at both 24 and
96 hours of exposure (Supplementary Fig. S5B). Interestingly,
cells surrounded by large Mitsui-7 agglomerates did not show
any signs of proliferation (data not shown), indicating that
such cellular interaction with large MWCNT agglomerates
might lead to possible cytostasis. A summary of the biological
FIG. 6. Profibrotic response of MWCNT-exposed lung cell cultures, following acute or prolonged exposure. TGF-b, PD-
GF, and OPN secretion in (A) A549, (B) THP-1, and (C) MRC-5 cell cultures after 24- and 96-hour exposure to different
concentrations of Mitsui-7 MWCNTs. Interferon-gamma (1 lg/mL) was used as a positive control for TGF-b and TGF-b
(100 ng/mL) was used as positive control for PD-GF and OPN induction, respectively. *Represents a significant increase
( p < 0.05) compared to the negative control at 24-hour time point. #Indicates statistical significance in lung cultures at
96 hours, compared to the negative control ( p < 0.05). TGF-b, total transforming growth factor-1; PD-GF, platelet derived-
growth factor-AA; OPN, osteopontin.
PROFIBROTIC ACTIVITY OF MWCNTS IN DIFFERENT LUNG CELLS 9
effects induced by acute or prolonged continuous exposure to
Mitsui-7 in the different tested cell types is shown in Supple-
mentary Table S1.
Discussion
Commercial and industrial interest worldwide in the
unique properties and multiple applications of CNTs has
led to a heightened increase in their production rate, concom-
itantly raising concerns as to their potential human health ef-
fects during their life cycle.5,42 Data obtained from in vivo
and in vitro studies indicated that exposure to CNTs of spe-
cific physicochemical characteristics (i.e., long length and
high rigidity) by inhalation can be associated with adverse
effects such as pulmonary fibrosis similar to those induced
by asbestos fibers.8,43,44 While several studies have investi-
gated the biological impact of CNTs in vitro after acute expo-
sures (up to 48 hours) using relatively high CNT concentrations
(up to 100lg/mL), the knowledge of extended exposure periods
to lower, occupationally relevant concentrations is limited.
Therefore, our aim was to evaluate the profibrotic potential of
two MWCNT forms (Mitsui-7 and Nanocyl-7000) and crystal-
line silica (as a positive particle control), following either acute
or prolonged exposure to three lung cell types relevant to the
development of fibrosis. The two types of MWCNTs were
chosen because of the differences in their physicochemical pro-
perties, for example, Mitsui-7 are longer and more rigid in com-
parison to Nanocyl-7000. Such properties have been previously
shown to impact the toxicological outcomes of exposure to
MWCNTs.22
In this study, the cell cultures were exposed to sublethal
concentrations of MWCNTs (5–20 lg/mL). Such concentra-
tions have been recommended by Borm et al. and Gangwal
et al.45,46 For instance, the alveolar mass retention of CNTs
was modeled and calculated in the range of 12.4–46.5 lg/
cm2 during 45 years of a working lifetime exposure.46 The
behavior of Mitsui-7 (BSA-dispersed) in culture medium
was recently resolved by using several analytical and imag-
ing techniques. In particular, Septiadi et al. determined the
delivered dose profile of Mitsui-7 in vitro following up to
48 hours of exposure using UV-Vis-NIR spectroscopy, opti-
cal imaging, and quartz crystal microbalance measurements.
By monitoring the depletion profile of MWCNTs in cell cul-
ture media, it was confirmed that*70% of CNTs sediments
on the bottom of the well, while the remaining was dispersed
in the medium (Septiadi et al., under review). Moreover, it is
important to note that in the 96-hour scenario, the applied
MWCNT concentrations were two fold higher than the
dose of 24-hour time frame as the medium-MWCNT suspen-
sion was refreshed (after 48 hours of continuous exposure).
However, according to the dosimetry findings above, a consid-
erable amount of CNTs underwent sedimentation, and thus di-
rectly interacted with the cell cultures. Considering the cell
growth area of 0.9 cm2 and the sedimentation rate, the final de-
livered dose of Mitsui-7, as described herein, to the cell cul-
tures is in the range of 3.5–15.3lg/cm2. This represents 3
months to 45 years of the human occupational exposure to
MWCNTs as previously described.44,46 The authors note,
however, that the dose herein was applied over only a 96-
hour period in vitro.
Studies have shown an indirect and a direct mechanism
leading to lung fibrosis.15,30 MWCNTs can induce lung fi-
brosis through the indirect pathway, which is mainly medi-
ated by macrophages and epithelial cells that represent the
cellular frontline of the alveolar region and release media-
tors, subsequently activating fibroblasts located in the under-
lying interstitium.15 In contrast to the indirect mechanism,
growing evidence confirms that CNTs can rapidly reach
the alveoli and directly act on fibroblasts, thus leading to
fibrosis.13 Therefore, in this study, the three most represen-
tative cell types involved in the indirect and direct patho-
genesis mechanism of fibrosis were selected and their
profibrotic activity upon different MWCNT concentrations
was examined. The importance of the selected cell types
has been further verified by Vietti and collegues, who sug-
gested that an adverse outcome pathway for CNT-induced
fibrosis should include the chosen panel of cell cultures.15
The rational to use monocultures was (i) to evaluate if the
different cell types, which are relevant for the onset of fibro-
sis, can be used under prolonged time periods and (ii) if
lower, more realistic concentrations of MWCNTs can induce
proinflammatory and/or profibrotic responses.
The Mitsui-7 MWCNTs used in this study are long with
length of up to 30 lm, have high rigidity and stiffness, and
have recently been classified as potentially carcinogenic to
humans (IARC, Group 2B).47 Recent in vivo studies indi-
cated that Mitsui-7 promote inflammatory and fibrotic effects,
as well as cause the onset of peritoneal mesothelioma upon
single intratracheal administration or intraperitoneal injec-
tion.8,48,49 Nanocyl-7000, another type of MWCNTs, has also
been evaluated in this study, and in contrast to Mitsui-7, has
been associated with low fibrotic activity in animal models.19,50
Despite the substantial number of in vivo tests conducted to in-
vestigate respiratory effects of Nanocyl-7000, information
about its fibrotic effects on in vitro cell cultures remains limited.
CNTs are highly hydrophobic materials, thus their ag-
glomeration in aqueous solution is inevitable.51 Several stud-
ies reported that the dispersion state of CNTs as well as the
type of dispersant used can influence the MWCNT-induced
cellular responses and, in particular, potential fibrotic reac-
tions.4,52 In this study, MWCNTs were dispersed in BSA, a
protein that has been also recommended by other studies as
a useful dispersant, since it has no impact on cell survival
or proliferation.30,53 Indeed, BSA resulted in a well-
dispersed MWCNT suspension. Notably, TEM images dis-
played the extensive morphological differences between
the two MWCNT types studied. Mitsui-7 appeared as sin-
glets or bundles of ‘‘needle like’’, with a rigid shape, while
the shorter Nanocyl-7000 consisted of highly entangled ag-
glomerated tubes. Size distribution of Mitsui-7 revealed a
significantly shorter average tube length compared to the
length reported by Poland et al.,8 possibly due to CNT frac-
ture during the sonication process. However, about 40% of
the tubes had length greater than 5lm and*10% of the fibers
were longer than 12lm. This observation is in agreement with
recent in vitro studies, where 2% mouse serum and 0.1%
Tween-80 were used as dispersants for Mitsui-7.54,55 Both
studies showed a similar average length (5–6lm) for the
same type of MWCNTs after sonication. In fact, Schinwald
et al. demonstrated that silver nanowires longer than 5lm
are suggested as the threshold length for macrophage impair-
ment and lung inflammation in mice studies.56
Visualization of the cells revealed an evident association of
Mitsui-7 with all the tested cell types. Single CNTs or small
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agglomerates were internalized by the cells, while large agglom-
erates strongly interacted with the outer cell membrane. Macro-
phages had a greater intensity of interaction with both
MWCNT types studied, compared to both the epithelial cells
and fibroblasts. This finding, however, could be easily attributed
to the enhanced phagocytic capacity of macrophages. Similar to
our findings, Septiadi et al. also showed that small deposited frac-
tions of Mitsui-7 were partly or fully internalized by A549 cells
(SeptiadiD,Rodriguez-LorenzoL,BalogS, et al. In vitro dosim-
etry of carbon nanotubes. Manuscript under review, 2018).
Unlike previous studies that showed that MWCNTs might
lead to cytotoxicity, no cytotoxicity was observed for all mate-
rials and cell types tested in this study. This difference in the cy-
totoxicity could be attributed to the fact that in previous studies,
extremely highMWCNT concentrations (100–150lg/mL) have
been used.57–59 Although no significant modifications were ob-
served in epithelial cells following acute exposure to Mitsui-7,
epithelial cultures did show significant altered morphology at
the highest MWCNT concentration (20lg/mL), at 96 hours.
In fact, notable disorganization of the F-actin cytoskeleton
with subsequent loss of the monolayer morphology was ob-
served as a result of prolonged MWCNT treatment. In line
with our observations, Polimeni et al. demonstrated similar ef-
fects in BEAS-2B bronchial epithelial cell morphology follow-
ing 96 hours of exposure toMitsui-7MWCNTs.53 Similarly, we
have shown that macrophages and fibroblasts displayed a clear
decrease in the visualized F-actin cytoskeleton expression, only
following extended continuous Mitsui-7 MWCNT exposure.
In the CNT safety assessment, several in vitro observations
consistently demonstrated oxidative stress as the predominant
mechanism of the CNT-induced toxicity. Importantly, in vivo
studies have confirmed that exposure to CNTs results in oxida-
tive stress in animal tissues as shown by alterations in both
GSH and heme-oxygenase-1 levels.60,61 Oxidative stress has
been also established as the key initiating event in the develop-
ment of fibrosis, as it promotes fibroblast to myofibroblast
transformation and activation by interacting with the TGF-b1
signaling pathway, and thus triggers the expression and secre-
tion of the critical profibrotic mediator TGF-b.62–64 Oxidative
stress reactions, as measured by either free radical formation or
a loss in antioxidant capacity, have been widely reported in
CNT-exposed epithelial cells in various in vitro studies.65,66
In our study, we did not observe a statistically significant in-
crease in oxidative stress for any of the treatment groups. How-
ever, A549 epithelial cells have shown signs of oxidative stress
after prolongedMitsui-7 exposure, which was more evident for
the two highest concentrations (10 and 20lg/mL) tested. In ad-
dition, THP-1 macrophages displayed a depletion of reduced
GSH after both 24- and 96-hour time frames. An explanation
for the increased loss in reduced GSH in macrophages could
be that cells might undergo frustrated phagocytosis, while try-
ing to engulf long MWCNTs, in turn secreting this protein
readily during this cellular phenomenon, since inefficient
phagocytosis has been related with increased reactive oxygen
species (ROS) production in an earlier report.67
Numerous in vitro and in vivo studies have suggested that
MWCNTs can induce lung fibrosis, although several molecular
mechanisms, including increased oxidative stress, enhanced re-
lease of proinflammatory and profibrotic mediators in lung
cells.68,69 Among the proinflammatory cytokines, IL-1b has
been shown to play a leading role in the development of fibro-
sis. Lysosomal damage in macrophages due to MWCNT treat-
ment can trigger IL-1b by inducing the assembly of the NLRP3
(NOD-like receptor family, pyrin domain containing-3)
inflammasome, which is responsible for the cleavage of pro-
IL-1b to active IL-1b.40 Upregulated IL-1b can act in cooper-
ation with the epithelial- and macrophage-produced profibrotic
TGF-b to promote epithelial-mesenchymal transition, which
results in fibroblast accumulation and subsequently elevated
collagen deposition in the lung.38,40 Our data show that expo-
sure to 5lg/mL Mitsui-7 induced a significant IL-1b increase
in both macrophages and fibroblasts after 24 hours, while A549
cells did not express this cytokine. Then, IL-1b secretion
slightly decreased, but remained elevated in macrophages at
96-hour time point, suggesting constant cell stimulation,
which could be associated with increased oxidative stress.
The elevated IL-1 b release at the lowest Mitsui-7 dose tested
can be explained from the fact that at low doses, MWCNTS
may be less agglomerated, and thus easily attach to the surface
and penetrate the cellular membrane. Similar observations
were shown by Fu et al. at low doses of graphene oxide parti-
cles, although not at high doses.70 Recently, Hamilton et al.
reported that MWCNTs could elicit the release of IL-1b in
THP-1 cells.71 Similarly, various in vitro studies have shown
enhanced IL-1b levels in different macrophage cell lines ex-
posed to CNTs by oxidative stress, nuclear factor-kappa B,
and inflammasome activation.69,72 Furthermore, IL-1b can
trigger the secretion of key profibrotic proteins, that is, TGF-
b and PD-GF, by different lung cell types, emphasizing the im-
portance of the intercellular communication through the re-
lease of proinflammatory mediators by macrophages.69
IL-8 is another important proinflammatory mediator, mainly
associated with acute inflammation. In this study, we did not
observe a statistically significant increase in IL-8 protein levels
in any of the cell types tested. However, we observed a slight
increase in IL-8 in THP-1 and fibroblast cells at the lowest
Mitsui-7 concentration, following acute exposure. Similarly,
long MWCNTs (50lg/mL) did not induce IL-8 release in pri-
mary alveolar type I and type II cells, while elicited significant
response in alveolar macrophages.57 Murphy et al. also
reported increased IL-8 release in Mitsui-7 (5lg/mL)-exposed
THP-1 cells, possibly due to frustrated phagocytosis.73
Mitsui-7 were found to significantly increase TGF-b and
PD-GF secretion into the supernatant of exposed epithelial
cells after 96 hours. Both proteins are crucial profibrotic
markers in the pathogenesis of pulmonary fibrosis. In partic-
ular, TGF-b produced by epithelial cells or macrophages has
been recognized as the most crucial endogenous regulator of
the differentiation of mesenchymal cells and collagen syn-
thesis, as it directly manages the de novo expression of a-
smooth muscle actin and the production of ECM proteins
i.e., collagen and fibronectin.64
Furthermore, PD-GF is a potent mitogen for cells of a mes-
enchymal origin, including fibroblasts.74 Increased PD-GF
boosts fibroblast proliferation and their differentiation into
myofibroblasts, aggravating fibrosis.69 Several in vitro studies
have shown increased TGF-b as well as PD-GF activity fol-
lowing MWCNT exposure.30,68,69 However, it is worth to
mention that most of the studies examining the role of epithe-
lial cells in pulmonary fibrosis have been performed mainly on
bronchial epithelial cell cultures and only limited studies in-
vestigated the function of the alveolar epithelium.15 Further-
more, both in vivo and in vitro studies have shown the
secretion of TGF-b and PD-GF from macrophages treated
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with MWCNTs.27,75 Similarly, elevated PD-GF and a slight
increase in TGF-b were observed after 96 hours of Mitsui-7
exposure in THP-1 cells. This induction of IL-1b, TGF-b,
and PD-GF by exposed macrophages further advocates their
indirect effects on fibroblasts and potentially contributes to
the pathogenesis of MWCNT-induced pulmonary fibrosis.
MWCNTs can also induce the release of TGF-b directly
from fibroblasts.64 He et al. observed upregulation of TGF-
b and PD-GF in fibroblasts after 24 hours of exposure to
20 lg/mL MWCNTs.69 The herein presented data also indi-
cated release of the same growth factors in fibroblasts upon
acute exposure to Nanocyl-7000, but not Mitsui-7. Signifi-
cant TGF-b release was demonstrated in Mitsui-7-treated fi-
broblasts only in the prolonged experimental approach,
which clearly attributes the difference in how rapid the pro-
fibrotic response occurs between different CNT types.
The release of the profibrotic marker OPN by mouse mac-
rophages after acute (24 hours) in vitro exposures to Mitsui-7
and Nanocyl-400 MWCNTs was recently reported.54 OPN is
primarily implicated in fibroblast proliferation as well as in fi-
broblast migration and formation of ECM.30 In particular, in-
creased OPN secretion was measured in mice 2 months after
MWCNT pharyngeal aspiration.30 Hussain et al. recently de-
termined that conditioned medium from MWCNT-exposed
human bronchial epithelial cells could result in increased
OPN activity in human lung fibroblasts, highlighting the im-
portance of epithelial-derived mediators in fibrotic reactions.28
Similarly, in this study, both epithelial A549 cells and THP-1
macrophages exhibited significant increase in OPN levels
mainly after prolonged treatments to different Mitsui-7 con-
centrations (5, 10, and 20lg/mL). OPN release was also ob-
served in Mitsui-7-exposed fibroblasts after both acute and
prolonged exposures.
Although Mitsui-7 MWCNT exposure increased TGF-b
and OPN release in MRC-5 fibroblasts upon prolonged expo-
sure, no increase in collagen production was observed. This is
in accordance with the cellular proliferation data since prolif-
eration was not increased in MWCNT-exposed cells. This ob-
servation might have two possible explanations. It could
suggest either that such effects might require a longer postin-
cubation time than the 96 hours used in this study or that the
increased cell surface coverage by MWCNTs observed in the
prolonged time point might, by some means, block fibroblast
activation. On the contrary, Wang et al. showed that exposure
to long and entangled MWCNTs (5lg/mL) for 48 hours in-
duced fibroblast proliferation and collagen production in
human CRL1490 fibroblasts.76 Another study confirmed the
stimulation of cell proliferation in different fibroblast human
and mouse cell lines (HFL-1, BALB-3T3, and MLg) follow-
ing a 24-hour exposure to short MWCNTs (0.7–3lm length)
at 37.5lg/cm2 concentration.30 The discordance may be
explained by the use of different CNT types, dispersion meth-
ods, cell lines, or test concentrations. In particular, depending
on the physicochemical properties among different types of
MWCNTs, their oxidative stress potential and their fibrotic re-
sponse appear to vary considerably.15
A previous animal study provided evidence that Nanocyl-
7000 MWCNTs elicited strong acute-phase inflammatory re-
sponse after intratracheal administration in mice.35 Durable
interstitial and granulomatous inflammation were also ob-
served in animal lungs after 90 days of inhalation exposure
to Nanocyl-7000.19,50 In line with those findings, our data
showed a pronounced IL-1b release in macrophages as
well as a notable IL-8 release in both epithelial and macro-
phage cultures after prolonged Nanocyl-7000 exposure. In
fact, animal reports have demonstrated that Nanocyl-7000
can also lead to fibrosis development, which, however, is not
as severe as the one observedwith longer types ofMWCNTs.35
In vivo results correlate with our in vitro findings, since
Nanocyl-7000 evoked a fibrogenic response, but to a lesser ex-
tent compared to Mitsui-7. However, it should be noted that
existing in vivo studies only reflect an acute scenario, and the
fact that some of the classic fibrotic markers are absent or
expressed to a lesser extent following exposure to Nanocyl
does not preclude the possibility that this CNT type might
still induce fibrosis through a different mechanism at different
doses or postexposure time points.
In parallel, the pulmonary fibrotic activity of lung cultures
exposed to crystalline silica, i.e., Min-U-Sil, was assessed, as
this material has shown fibrotic effects in vivo.29,30 Similar to
in vivo studies, our results demonstrated that Min-U-Sil
induced significant profibrotic effects in epithelial cells and
macrophage cultures following 96 hours of exposure, and
in fibroblasts following 24 hours of exposure. Notably, sig-
nificant collagen formation in fibroblasts was observed
only after prolonged exposure to Min-U-Sil, indicating that
fibroblast activation may require a longer time frame to
occur, compared to the first effects of fibrosis that is, fibrotic
marker release (TGF-b and PD-GF).
In addition, it was shown that a proinflammatory response
following exposure to Mitsui-7 MWCNTs can occur rapidly
following 24 hours of exposure, while signs of profibrotic ac-
tivity required a prolonged (96 hours) exposure, which points
out the importance of evaluating hazard assessment upon
long-term exposure periods. This finding correlates with a re-
cent in vivo report, where fibrotic effects of Mitsui-7 were
apparent at time points later than 28 days.77
Conclusion
The purpose of this study was to gain an insight into the
early profibrotic activity of three key lung cell monocul-
tures involved either directly or indirectly in the develop-
ment of pulmonary fibrosis. Unlike most in vitro toxicity
studies, the biological impact was evaluated not only upon
acute exposures (24 hours) but also after a prolonged incuba-
tion time (96 hours). Following each exposure period, a
panel of crucial mediators was assessed, carefully selected
for their predictive fibrotic capability. However, it should
be pointed out that existing in vitro assays are not able to pre-
dict the disease in its entirety, so more research is required in
future studies in that perspective. The results have shown that
exposure to MWCNTs affected each cell type differently.
Exposure to long, rigid MWCNTs, but not short MWCNTs,
resulted in a proinflammatory response in macrophages
and fibroblasts, although predominantly after only 24 hours
of exposure. Notably, profibrotic effects were observed in
all tested cell types, following prolonged MWCNT incuba-
tion (96 hours), thus indicating that long-term exposures can
be considered more suitable to predict the early signs of fibrosis
in vitro. For future studies, it is recommended to investi-
gate the long-term effects of low nanomaterial concentra-
tions in vitro using more physiologically relevant 3D cellular
models.
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